| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035313 |
| Receipt No. | R000040238 |
| Scientific Title | Elucidation of the effect of tea-derived food materials on sleep |
| Date of disclosure of the study information | 2018/12/19 |
| Last modified on | 2021/06/21 (Ver. 2) |
| Basic information | ||
| Public title | Elucidation of the effect of tea-derived food materials on sleep | |
| Acronym | The effect of tea-derived food materials on sleep | |
| Scientific Title | Elucidation of the effect of tea-derived food materials on sleep | |
| Scientific Title:Acronym | The effect of tea-derived food materials on sleep | |
| Region |
|
|
| Condition | ||
| Condition | Health subject | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to elucidate the effect of tea-derived food materials on sleep. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Percent of sleep stages evaluated polysomnography, Energy expenditure |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 6 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | A. Tea-derived food materials
B. Placebo1 including caffeine C. Placebo2 Each food materials is taken for 2 weeks in the order of A, B, C, and a washout period of 2 weeks or more is set between each intake. The order of food intake is (A,B,C). |
|
| Interventions/Control_2 | The order of food intake is (A,C,B). | |
| Interventions/Control_3 | The order of food intake is (B,A,C). | |
| Interventions/Control_4 | The order of food intake is (B,C,A). | |
| Interventions/Control_5 | The order of food intake is (C,A,B). | |
| Interventions/Control_6 | The order of food intake is (C,B,A). | |
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Healthy subject | |||
| Key exclusion criteria | Participants will be excluded from the experiment based on the following criterias.
1. Systolic blood pressure below 90mmHg 2. Currently participating or has participated in other experimental studies 4 weeks prior to the experiment day 3. Those that meet the following a. Diagnosed of heart, liver, or kidney disease b. Medical history in circulatory system diseases c. Diagnosed of diabetes d. Allergies to experimental food 4. Claustrophobic 5. Physician screened the individual out of the experiment 6. Under medication or consumes functional food and dietary supplements 7. Medical history with liver, kidney, or cardiac failures 8. Below 20 or above 60 years of age 9. Treated or currently being treated of sleep or mental disorder 10. Irregular lifestyle (Regular: sleep time between 9pm and 1am, wake time between 6am and 9am, 7-9 hours of sleep) 11. BMI less than 18.5 or greater than 25 12. Worked night shifts (after 10pm) 3 months prior to the experiment 13. Travel across time zones with time difference of 3 hours or more, 3 months prior to the experiment 14. Consumes alcohol regularly (40g (2 cans of beer) or more twice a week a more) 15. Smoker 16. Consumes more than 300mg (5 cups of 150mL) of coffee every day 17. MEQ score of less than 30 (extreme evening type) or greater than 70 (extreme morning type) 18. ESS score of greater than 11 19. PSQI score of greater than 5.5 20. Weighs less than 36.3kg 21. Diagnosed or suspected of intestinal atresia or poor functioning in the digestive tract 22. Problems with emissary 23. History of being conducted of gastrointestinal surgery 24. Plans on getting a nuclear magnetic resonance (NMR), magnetic resonance imaging (MRI), or other procedures involving radio wave scans during the study period 25. Those who utilize implanted device such as a pacemaker The above exclusion criteria do not apply to those conducting this research. |
|||
| Target sample size | 12 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | International Institute for Integrative Sleep Medicine (WPI-IIIS) | ||||||
| Zip code | |||||||
| Address | Tennodai, Tsukuba, Ibaraki 305-8575, Japan | ||||||
| TEL | 029-853-3301 | ||||||
| yanagisawa.masa.fu@u.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | International Institute for Integrative Sleep Medicine (WPI-IIIS) | ||||||
| Zip code | |||||||
| Address | Tennodai, Tsukuba, Ibaraki 305-8575, Japan | ||||||
| TEL | 029-853-8080 | ||||||
| Homepage URL | |||||||
| kokubo.toshio.fp@u.tsukuba.ac.jp | |||||||
| Sponsor | |
| Institute | University of Tsukuba |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The National Agriculture and Food Research Organization |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000040238 |